Abstract
This study reviews the renal aspects of diuretic resistance occurring in diuretic treatment, mostly with loop diuretics of congestive heart failure. A short discussion on the different classes of diuretics, including the recently introduced sodium-glucose transporter 2 inhibitors, and their mechanism of action in the nephron is provided, followed by a summary of recent data discussing the different causes and pathophysiological mechanisms of diuretic resistance. The major cause of diuretic resistance appears to be localized within the distal tubule. Traditionally, the concept of compensatory post-diuretic sodium reabsorption (CPDSR) was considered the major cause of diuretic resistance; however, recent studies have disputed this traditional concept and demonstrated that patients with congestive heart failure are in constant sodium-avid state. Finally, the different options of therapeutic strategies, combining different classes of diuretics are summarized.
Reference105 articles.
1. Diuretic Resistance;Hoorn;Am. J. Kidney Dis.,2017
2. Renal effects of guideline-directed medical therapies in heart failure: A consensus document from the Heart Failure Association of the European Society of Cardiology;Mullens;Eur. J. Heart Fail.,2022
3. Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure;Wilcox;Hypertension,2020
4. Clinical Pharmacology in Diuretic Use;Ellison;Clin. J. Am. Soc. Nephrol.,2019
5. Turner, N., Lameire, N., Goldsmith, D.J., Winearls, C.G., Himmelfarb, J., and Remuzzi, G. (2016). Oxford Textbook of Clinical Nephrology, Oxford University Press. [4th ed.].
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献